Partners & Collaborators

Medicine & Life Sciences

1. HIV 100%
2. Wounds and Injuries 79%
3. Infections 71%
4. Military Personnel 58%
5. Afghanistan 48%
6. Military Health Services 37%
7. Wound Infection 36%
8. Iraq 35%
9. Highly Active Antiretroviral Therapy 34%
10. Acinetobacter calcoaceticus 32%
11. Extremities 32%
12. Otolaryngology 30%
13. Acinetobacter baumannii 29%
14. Communicable Diseases 28%
15. Natural History 28%
16. HIV Infections 28%
17. Coronavirus 28%
18. Military Facilities 26%
19. Severe Acute Respiratory Syndrome 24%
20. Population 24%
21. Invasive Fungal Infections 23%
22. Guidelines 23%
23. Therapeutics 23%
24. Cohort Studies 20%
25. Dengue Virus 20%
26. Vaccines 20%
27. Fungi 20%
28. Epidemiology 20%
29. Cochlear Implantation 19%
30. Soft Tissue Infections 19%
31. Human Influenza 19%
32. CD4 Lymphocyte Count 18%
33. Hepatitis B virus 18%
34. Armed Conflicts 18%
35. Dengue 18%
36. Confidence Intervals 17%
37. Staphylococcus aureus 17%
38. Telemedicine 17%
39. Critical Care 16%
40. Continuous Renal Replacement Therapy 16%
41. SARS Virus 16%
42. Anti-Bacterial Agents 16%
43. Afghan Campaign 2001- 16%
44. Hepatitis B Vaccines 16%
45. Extracorporeal Membrane Oxygenation 16%
46. Intensive Care Units 15%
47. Carbapenems 15%
48. Odds Ratio 15%
49. 2003-2011 Iraq War 15%
50. Klebsiella pneumoniae 15%
51. Bacteria 14%
52. Methicillin-Resistant Staphylococcus aureus 14%
53. Vaccination 14%
54. Rheumatology 13%
55. Kidney 13%
56. GS-5734 13%
57. Skin 12%
58. Lower Extremity 12%
59. Acinetobacter 12%
60. Bacillus 12%
61. Critical Illness 12%
62. Otolaryngologists 12%
63. T-Lymphocytes 12%
64. Cefazolin 12%
65. Tranexamic Acid 12%
66. Veterans 12%
67. Virus Diseases 11%
68. Antibodies 11%
69. Health Care Outcome Assessment 11%
70. Military Hospitals 11%
71. United States Department of Defense 11%
72. Coronavirus Infections 11%
73. Delivery of Health Care 11%
74. Hepatitis B 11%
75. Hospitalization 10%
76. Acquired Immunodeficiency Syndrome 10%
77. Doxycycline 10%
78. Viral Load 10%
79. Infection Control 10%
80. Open Fractures 10%
81. Antibody-Dependent Enhancement 10%
82. Disk Diffusion Antimicrobial Tests 10%
83. Amputation 10%
84. Ecosystem 10%
85. Mortality 10%
86. Mosquito Vectors 9%
87. Air 9%
88. Influenza Vaccines 9%
89. In Vitro Techniques 9%
90. Vaccine Immunogenicity 9%
91. Blast Injuries 9%
92. Muscles 9%
93. Military Medicine 9%
94. Practice Guidelines 9%
95. Diarrhea 9%
96. Hepatitis A virus 9%
97. Septic Shock 9%
98. Polymerase Chain Reaction 9%
99. Serum 9%
100. Nose 9%